India's thriving biotechnology industry is threatened by a change in the law. Will the current high levels of investment be enough to secure its future? K. S. Jayaraman finds out.
This is a preview of subscription content, access via your institution
Access options
Subscribe to Journal
Get full journal access for 1 year
$199.00
only $3.90 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.

Author information
Author notes
K. S. Jayaraman is Nature's India correspondent.
- K. S. Jayaraman
Rights and permissions
About this article
Cite this article
Jayaraman, K. Biotech boom. Nature 436, 480–483 (2005). https://doi.org/10.1038/436480a
Published:
Issue Date:
DOI: https://doi.org/10.1038/436480a
This article is cited by
-
Managing Dual Use Technology: It Takes Two to Tango
Science and Engineering Ethics (2010)
-
India's health biotech sector at a crossroads
Nature Biotechnology (2007)
-
Biotech boom
Nature Biotechnology (2005)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.